What is the aim of the ENCODE project?
Barr bodies are not present in which of the following chromosomal complements?
The study of the multiplication of proteins in a disease process is called:
Which of the following statements about microRNAs (miRNAs) is false?
What is the codon for the initiation of protein synthesis?
Base substitution mutations can have the following molecular consequences EXCEPT:
Where is ribosomal RNA (rRNA) mainly produced?
What is the most common form of DNA variation?
Lyon's hypothesis refers to which phenomenon in females?
Which of the following is NOT a characteristic of restriction endonucleases?
Explanation: **Explanation:** The **ENCODE (Encyclopedia of DNA Elements)** project was launched by the National Human Genome Research Institute (NHGRI) as a follow-up to the Human Genome Project. While the Human Genome Project focused on "reading" the sequence, ENCODE aims to **identify and characterize all functional elements** within the human genome. This includes protein-coding regions, non-coding RNA genes, regulatory elements (promoters, enhancers, silencers), and regions of chromatin modification. A key finding of ENCODE is that approximately 80% of the genome has some biochemical function, debunking the older concept of "junk DNA." **Analysis of Incorrect Options:** * **Option A:** Sequencing of the human genome was the primary goal of the **Human Genome Project (HGP)**, completed in 2003. * **Option B:** Metagenome analysis of intestinal flora is the focus of the **Human Microbiome Project (HMP)**, which studies the microbial communities inhabiting the human body. * **Option D:** Analysis of the mitochondrial genome (the 16.5 kb circular DNA) is a specific area of genetics but is not the objective of the ENCODE project, which focuses on the 3.2 billion base pairs of the nuclear genome. **High-Yield Facts for NEET-PG:** * **Functional Elements:** ENCODE identifies elements like **H3K4me3** (associated with promoters) and **CTCF-binding sites** (insulators). * **Non-Coding DNA:** Most disease-associated SNPs (Single Nucleotide Polymorphisms) identified in GWAS studies lie in the non-coding functional regions identified by ENCODE, not in exons. * **HapMap Project:** Another related project that maps common patterns of human genetic variation (haplotypes).
Explanation: ### Explanation The presence of **Barr bodies** (sex chromatin) is a result of **Lyonization**, the process of random X-inactivation. To maintain dosage compensation between males and females, only one X chromosome remains active in a somatic cell; all additional X chromosomes are inactivated and condensed into heterochromatin (Barr bodies). The formula to determine the number of Barr bodies is: **Number of Barr Bodies = Total number of X chromosomes – 1** #### Why XO is the Correct Answer: * **XO (Turner Syndrome):** In this complement, there is only one X chromosome. Applying the formula (1 – 1 = 0), there are **no Barr bodies**. Since there is no "extra" X chromosome to inactivate, the cell remains negative for sex chromatin. #### Why the Other Options are Incorrect: * **XX (Normal Female):** Contains two X chromosomes. One undergoes inactivation (2 – 1 = 1), resulting in **1 Barr body**. * **XXY (Klinefelter Syndrome):** Despite being phenotypically male due to the Y chromosome, the presence of two X chromosomes leads to the inactivation of one (2 – 1 = 1), resulting in **1 Barr body**. * **XXX (Triple X Syndrome):** Contains three X chromosomes. Two are inactivated (3 – 1 = 2), resulting in **2 Barr bodies**. #### High-Yield Clinical Pearls for NEET-PG: * **Lyon Hypothesis:** X-inactivation occurs early in embryonic life (blastocyst stage, approx. 16th day) and is **irreversible and random**. * **XIST Gene:** Located on the X-inactivation center (Xic) of the X chromosome, it produces a non-coding RNA that "coats" the chromosome to be inactivated. * **Staining:** Barr bodies are typically visualized at the periphery of the nucleus using **Feulgen stain** or in neutrophils as **"Drumsticks."** * **Buccal Smear:** This is the classic clinical test used to detect Barr bodies.
Explanation: **Explanation:** **1. Why Proteomics is Correct:** Proteomics is the large-scale study of **proteomes**, which refers to the entire set of proteins expressed by a genome, cell, tissue, or organism at a given time. In a disease process, protein expression, modifications, and "multiplication" (abundance/synthesis) change dynamically. Since proteins are the functional molecules that execute cellular processes, studying their alterations is crucial for understanding disease mechanisms, identifying biomarkers, and developing targeted therapies. **2. Why Other Options are Incorrect:** * **Genomics:** This is the study of the complete set of DNA (genes) within an organism. While it provides the "blueprint," it does not account for dynamic changes in protein levels or post-translational modifications occurring during disease. * **Glycomics:** This refers to the comprehensive study of **glycans** (carbohydrates/sugars) and their structures and functions, particularly those attached to proteins (glycoproteins) and lipids. * **Nucleomics:** This is a less common term often used to describe the study of the structure and function of the cell nucleus and its components (the nucleome). **Clinical Pearls for NEET-PG:** * **Central Dogma:** DNA (Genomics) → mRNA (Transcriptomics) → Protein (**Proteomics**). * **Dynamic Nature:** Unlike the genome, which is relatively static, the proteome is highly dynamic and changes in response to external stimuli and disease states. * **Post-translational modifications (PTMs):** Proteomics is essential for studying PTMs (like phosphorylation or glycosylation), which are critical in signaling pathways and cancer. * **Technique:** **Mass Spectrometry** is the gold standard tool used in proteomic analysis.
Explanation: **Explanation:** **1. Why Option B is the correct (false) statement:** MicroRNAs (miRNAs) are a class of **non-coding RNAs**. By definition, non-coding RNAs do not contain an open reading frame (ORF) and are not translated into proteins. Their primary function is regulatory, acting at the post-transcriptional level to modulate the expression of other protein-coding genes. **2. Analysis of incorrect options:** * **Option A & C:** These are true. miRNAs are potent **gene silencers**. They function by binding to the 3' untranslated region (3' UTR) of target messenger RNA (mRNA). This binding leads to either **mRNA degradation** (if the complementarity is perfect) or **translational repression** (if the complementarity is partial), thereby inhibiting gene expression. * **Option D:** This is true. Mature miRNAs are small molecules, typically ranging from **21 to 25 nucleotides** (though the broader category of small non-coding RNAs can extend up to 30 nucleotides). They are processed from longer primary transcripts (pri-miRNA) by enzymes **Drosha** (in the nucleus) and **Dicer** (in the cytoplasm). **Clinical Pearls & High-Yield Facts for NEET-PG:** * **RISC Complex:** miRNAs function as part of the **RNA-induced silencing complex (RISC)**. * **OncomiRs:** miRNAs that regulate oncogenes or tumor suppressor genes. Dysregulation of miRNAs is linked to various cancers (e.g., miR-21 is often overexpressed in tumors). * **Seed Sequence:** The 2nd to 7th nucleotides at the 5' end of the miRNA are crucial for target recognition. * **Therapeutic Potential:** miRNA mimics and "antagomirs" (antisense oligonucleotides) are being researched as potential targeted therapies for genetic disorders and malignancies.
Explanation: ### Explanation **Correct Answer: A. AUG** In molecular biology, the **initiation of protein synthesis** (translation) is triggered by a specific start codon on the mRNA. **AUG** is the universal start codon. It serves two primary functions: 1. It signals the ribosome to begin translation. 2. It codes for the amino acid **Methionine** in eukaryotes and **N-formylmethionine (fMet)** in prokaryotes. --- ### Analysis of Incorrect Options: * **B. GLA:** This is not a standard genetic codon. It is likely a distractor. (Note: Glutamic acid is coded by GAA/GAG). * **C. UGA:** This is one of the three **Stop Codons** (Nonsense codons). It signals the termination of protein synthesis, not the initiation. * **D. UAG:** This is also a **Stop Codon** (specifically known as the "Amber" codon). --- ### NEET-PG High-Yield Pearls: * **Stop Codons (Nonsense Codons):** Remember them using the mnemonic "U Are Away, U Are Gone, U Go Away" (**UAA, UAG, UGA**). These do not code for any amino acid. * **Wobble Hypothesis:** Proposed by Francis Crick, it explains why multiple codons can code for a single amino acid (Degeneracy), usually differing at the 3rd base. * **Clinical Correlation:** Certain antibiotics target translation. For example, **Aminoglycosides** bind to the 30S ribosomal subunit and interfere with the initiation complex, causing misreading of the mRNA. * **Non-Standard Start:** In rare mitochondrial sequences, codons like GUG or UUG may occasionally act as start signals, but **AUG** remains the gold standard for the NEET-PG curriculum.
Explanation: **Explanation:** The core concept here is the distinction between **Point Mutations (Base Substitutions)** and **Frameshift Mutations**. **Why Option C is the correct answer:** A base substitution involves the replacement of a single nucleotide with another (e.g., Adenine replaced by Guanine). Because the total number of nucleotides remains the same, the **reading frame is preserved**. Frameshift mutations, which alter the reading frame downstream, are caused by **insertions or deletions (indels)** of a number of nucleotides not divisible by three, not by simple substitutions. **Analysis of Incorrect Options:** * **Option A (Silent Mutation):** This occurs when a base substitution changes a codon to another that codes for the same amino acid (due to the degeneracy of the genetic code). * **Option B (Missense Mutation):** This occurs when a base substitution results in a codon that codes for a different amino acid (e.g., Glutamate to Valine in Sickle Cell Anemia). * **Option D (Nonsense Mutation):** This occurs when a base substitution creates a premature stop codon (UAA, UAG, or UGA), leading to a truncated, usually non-functional protein. **Clinical Pearls for NEET-PG:** * **Sickle Cell Anemia:** A classic **Missense mutation** (GAG → GTG) where Glutamic acid is replaced by Valine at the 6th position of the β-globin chain. * **Duchenne Muscular Dystrophy (DMD):** Often caused by **Frameshift mutations** (deletions), whereas the milder Becker’s variant usually maintains the reading frame. * **Transitions vs. Transversions:** Transitions (Purine to Purine) are more common than Transversions (Purine to Pyrimidine).
Explanation: **Explanation:** The **nucleolus** is a non-membrane-bound sub-compartment within the nucleus and is the primary site for the **transcription and processing of ribosomal RNA (rRNA)**, as well as the assembly of ribosomal subunits. 1. **Why the Nucleolus is Correct:** The nucleolus contains "Nucleolar Organizer Regions" (NORs), which are clusters of genes (on chromosomes 13, 14, 15, 21, and 22) that code for 45S pre-rRNA. **RNA Polymerase I** transcribes these genes into 28S, 18S, and 5.8S rRNA. These rRNAs then combine with ribosomal proteins (imported from the cytoplasm) to form the 40S and 60S subunits before being exported back to the cytoplasm. 2. **Why Other Options are Incorrect:** * **Nucleus:** While the nucleolus is *inside* the nucleus, the nucleolus is the specific functional site for rRNA. The rest of the nucleus is primarily involved in DNA replication and mRNA/tRNA transcription. * **Ribosome:** These are the sites of **protein synthesis (translation)**, not rRNA production. They are composed *of* rRNA and proteins. * **Endoplasmic Reticulum (ER):** The Rough ER is studded with ribosomes and is involved in the synthesis of membrane-bound or secreted proteins. It has no role in rRNA synthesis. **High-Yield Clinical Pearls for NEET-PG:** * **RNA Polymerase I** transcribes all rRNA **except 5S rRNA** (which is transcribed by RNA Polymerase III in the nucleoplasm). * **Nucleolar hypertrophy** (enlarged nucleoli) is a classic histological marker of malignant cells due to high protein synthesis demands. * **Acrocentric Chromosomes:** The genes for rRNA are located on the short arms of acrocentric chromosomes (13, 14, 15, 21, 22).
Explanation: ### Explanation **Correct Answer: A. Single nucleotide polymorphism (SNP)** **Why it is correct:** Single Nucleotide Polymorphisms (SNPs) are the most common type of genetic variation among people. A SNP represents a difference in a single nucleotide (adenine, thymine, cytosine, or guanine) at a specific position in the genome. For a variation to be classified as a SNP, it must occur in at least **1% of the population**. On average, SNPs occur once in every 300 to 1,000 nucleotides, meaning there are roughly 4 to 5 million SNPs in a person's genome. **Why the other options are incorrect:** * **B. Copy Number Variations (CNVs):** These involve structural variations where sections of the genome are repeated or deleted. While they account for significant genetic diversity by total base pair count, they occur much less frequently than SNPs. * **C. Transposons:** Also known as "jumping genes," these are DNA sequences that move locations within the genome. While they contribute to evolution, they are not the primary unit of common variation. * **D. Mutations:** In genetics, the term "mutation" usually refers to a permanent change in DNA that occurs in **less than 1%** of the population. SNPs are essentially common, non-pathogenic mutations that have persisted in the population. **High-Yield Facts for NEET-PG:** * **SNP Frequency:** Occurs approximately every 1 kb of DNA. * **Transition vs. Transversion:** Transitions (Purine to Purine or Pyrimidine to Pyrimidine) are more common than transversions. * **Clinical Significance:** SNPs are used as biological markers to locate genes associated with complex diseases (e.g., Diabetes, Hypertension) and are the basis for **Pharmacogenomics** (predicting an individual’s response to drugs). * **RFLP:** SNPs can create or destroy restriction enzyme sites, leading to Restriction Fragment Length Polymorphisms used in DNA fingerprinting.
Explanation: **Explanation:** **Lyon’s Hypothesis** (also known as X-inactivation) describes the process by which one of the two X chromosomes in female mammals is inactivated. This occurs early in embryonic development (around the blastocyst stage) to ensure **dosage compensation**, so that females (XX) do not produce double the amount of X-linked gene products compared to males (XY). 1. **Why Option B is Correct:** The inactivation is **random** (can be maternal or paternal X), **fixed** (once inactivated, all clonal descendants have the same X inactive), and **incomplete**. The inactive X chromosome undergoes **heterochromatinization** (condensation into dense, transcriptionally silent chromatin), becoming visible as the **Barr body** at the periphery of the nucleus. 2. **Why Other Options are Incorrect:** * **Option A:** Females do not possess a Y chromosome; therefore, its inactivation is impossible. * **Option C:** The hypothesis specifically describes the *silencing* (inactivation) of an active chromosome, not the activation of one. **High-Yield Clinical Pearls for NEET-PG:** * **XIST Gene:** Located in the X-inactivation center (Xic), it produces a long non-coding RNA that "coats" the X chromosome to trigger silencing. * **Barr Body Formula:** Number of Barr bodies = (Total number of X chromosomes – 1). * *Turner Syndrome (45, XO):* 0 Barr bodies. * *Klinefelter Syndrome (47, XXY):* 1 Barr body. * **Mosaicism:** Because inactivation is random, females are "genetic mosaics"—some cells express the maternal X, others the paternal X. This explains why female carriers of X-linked recessive traits (like Hemophilia) usually do not show severe symptoms.
Explanation: **Explanation:** Restriction Endonucleases (REs), often called "molecular scissors," are enzymes that recognize and cleave specific double-stranded DNA sequences. **Why Option D is the Correct Answer:** Restriction endonucleases do **not** cut DNA randomly. Their defining feature is **sequence specificity**. They recognize specific "recognition sites" (usually 4–8 base pairs long) and cleave the phosphodiester backbone only at or near those sites. Enzymes that cut DNA randomly are generally referred to as non-specific nucleases (e.g., DNase I). **Analysis of Incorrect Options:** * **Option A:** This is a core characteristic. REs are highly specific, ensuring that a particular DNA molecule will always be cut into the same set of fragments when treated with the same enzyme. * **Option B:** RE nomenclature follows a standard rule: the first letter is the genus, the next two are the species, and the Roman numeral indicates the order of discovery (e.g., **EcoRI** comes from ***E***scherichia ***co***li, strain **R**, **I**st discovered). * **Option C:** Most Type II REs (used in labs) recognize **palindromic sequences**, where the 5' to 3' sequence is identical on both strands (e.g., 5'-GAATTC-3' and 3'-CTTAAG-5'). **High-Yield Clinical Pearls for NEET-PG:** * **Biological Function:** In bacteria, REs serve as a defense mechanism against viral (bacteriophage) DNA. * **Protection:** The bacteria's own DNA is protected from these enzymes by **methylation** of the recognition sites. * **Blunt vs. Sticky Ends:** REs can produce "sticky ends" (staggered cuts like EcoRI) or "blunt ends" (straight cuts like SmaI). Sticky ends are preferred in recombinant DNA technology for easier ligation. * **RFLP:** Restriction Fragment Length Polymorphism uses REs to detect genetic variations/mutations.
DNA Replication and Repair Mechanisms
Practice Questions
Transcription Factors and Gene Regulation
Practice Questions
Epigenetics and DNA Methylation
Practice Questions
RNA Processing and Splicing
Practice Questions
miRNA and RNA Interference
Practice Questions
Protein Synthesis and Post-Translational Modifications
Practice Questions
Genomics and Human Genome Project
Practice Questions
Single Nucleotide Polymorphisms
Practice Questions
Gene Therapy Approaches
Practice Questions
CRISPR-Cas9 and Genome Editing
Practice Questions
DNA Fingerprinting and Forensics
Practice Questions
Molecular Basis of Genetic Diseases
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free